Viewing Study NCT00173823



Ignite Creation Date: 2024-05-05 @ 11:55 AM
Last Modification Date: 2024-10-26 @ 9:16 AM
Study NCT ID: NCT00173823
Status: UNKNOWN
Last Update Posted: 2006-03-13
First Post: 2005-09-13

Brief Title: Malnutrition and Inflammation in Dialysis Patients in Taiwan
Sponsor: National Taiwan University Hospital
Organization: National Taiwan University Hospital

Study Overview

Official Title: Malnutrition and Inflammation in Taiwan Prospective Outcome Evaluation Method MIT-POEM in Dialysis Patients
Status: UNKNOWN
Status Verified Date: 2005-08
Last Known Status: RECRUITING
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: According to the reports of the United States Renal Data System USRDS there is a 25 annual mortality rate with nearly 50 of all reported maintenance hemodialysis HD patient deaths attributed to atherosclerosis-related complications Although traditional risk factors of cardiovascular disease CVD are common in end-stage renal disease ESRD patients they alone may be insufficient to account for their high prevalence of CVD Recent evidence demonstrated high plasma homocysteine levels have been established as a risk factor of chronic inflammation and atherosclerosis in patients with ESRD

Malnutrition and inflammation was associated with poor quality of life morbidity and mortality We the researchers at National Taiwan University Hospital hope to establish the best predictive profile of HD patient outcome Thus we establish several protocols to complete this work
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None